论文部分内容阅读
为了观察和评价晚期胰腺癌持续腹腔动脉插管化疗效果，对７例晚期胰腺癌患者行腹腔动脉插管并留置，６例采用ＴＨＰＡＤＭ＋ＨＣＰＴ＋ＣＦ／５Ｆｕ方案，另１例采用Ｇｅｍｃｉｔａｂｉｎｅ＋ＣＦ／５Ｆｕ方案，持续滴注４ｄ。结果完全缓解１例，部分缓解３例，无变化２例，进展１例，有效率为５７．１％（４／７），临床受益疗效７１．４％（５／７）。２例已死亡，５例生存，中位生存期５个月。结果表明持续腹腔动脉插管化疗对晚期胰腺癌有较好疗效，值得临床进一步观察研究。
In order to observe and evaluate the efficacy of continuous celiac artery catheterization for advanced pancreatic cancer, 7 patients with advanced pancreatic cancer were intubated and indwelled with celiac artery. Six patients were treated with THP-ADM+HCPT+CF/5-Fu and the other one was treated with Gemcitabine+CF/5. Fu program, continuous drip 4d. Results There was complete remission in 1 case, partial remission in 3 cases, no change in 2 cases, and progress in 1 case. The effective rate was 57.1% (4/7), and the clinical benefit was 71.4% (5/7). Two patients died and five patients survived. The median survival period was 5 months. The results show that continuous celiac artery catheterization chemotherapy has good curative effect on advanced pancreatic cancer and is worthy of clinical observation.